Cannabis got a big boost from international health authorities when the United Nation’s World Health Organisation said that CBD should not be scheduled as a controlled substance, an initial finding that comes about a month after the agency reviewed cannabidiol therapies.

The World Health Organisation also said that it wants to undertake a complete review of cannabis and has scheduled a May review of “cannabis and cannabis related substances.”

Recommendations from the World Health Organisation, an agency of the United Nations, don’t carry the force of law, but they are important guideposts for health authorities worldwide.

The agency’s evaluation of new drug therapies carry big consequences for drug makers and patients.

There is increased interest from Member States in the use of cannabis for medical indications including for palliative care. Responding to that interest and increase in use, the World Health Organisation has gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.

The Expert Committee on Drug Dependence (ECDD) did an initial review of a cannabis compound called CBD.

Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions.

Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC).

The ECDD therefore concluded that current information does not justify scheduling of cannabidiol.

A final decision on CBD is expected at the 40th Expert Committee on Drug Dependence (ECDD) which will be held in May 2018 at the WHO Headquarters in Geneva.

For further information from the World Health Organisation on the scheduling of CBD, use the following link > WHO - Cannabidiol.

Medical Cannabis is a great treatment for the management of chronic pain and illness. Research into the positive medicinal benefits of cannabis has led to overwhelming demand for cannabis strains that contain medicinal properties.

Our Ultimate Guide to Medical Cannabis Seeds is one of the best resources on the Internet for Medical Cannabis Seeds Information and Medical Cannabis Links.

The information contained on our website is intended as a guide and anyone seeking to use cannabis medicinally should consult their doctor beforehand.

We offer 115 of the best CBD Cannabis strains for medical users, including collections from renowned breeders Royal Queen Seeds, Sweet Seeds, Dutch Passion, OO Seeds, Original Sensible Seeds and Barney's Farm.

Here's 4 of the best CBD Rich, low THC strains:

• Royal Queen Seeds > Solomatic Auto, 21% CBD and only 1% THC.
• Auto Seeds > Sweet Auto, 15% CBD and only 1% THC.
• Female Seeds > Terra Italia, 12-14% CBD and only 0.3% THC.
• Fast Buds > Auto 20:1, Up to 20% CBD and less than 1% THC.